Interleukin-5 and IL-5 receptor in health and diseases

Proceedings of the Japan Academy Series B: Physical and Biological Sciences

Volumn 87, Issue 8, 2011, Pages 463-485

  Takatsu, Kiyoshi ^a,b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b Toyama Prefectural Institute of Pharmaceutical Research   (Japan)

Author keywords

Acquired immunity; Asthma; B cells; Cytokine; Eosinophil; Innate immunity

Indexed keywords

INTERLEUKIN 5; INTERLEUKIN 5 RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; DISEASES; GENETICS; HEALTH; HUMAN; IMMUNITY; METABOLISM; MOLECULAR GENETICS; REVIEW; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; DISEASE; HEALTH; HUMANS; IMMUNITY; INTERLEUKIN-5; MOLECULAR SEQUENCE DATA; RECEPTORS, INTERLEUKIN-5; SIGNAL TRANSDUCTION;

EID: 82355162913     PISSN: 03862208     EISSN: 13492896     Source Type: Journal    
DOI: 10.2183/pjab.87.463     Document Type: Review

References (130)

1. Medzhitov, R. (2001) Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1, 135-145.
2. Akira, S., Uematsu, S. and Takeuchi, O. (2006) Pathogen recognition and innate immunity. Cell 124, 783-804.
3. Eisenbarth, S.C., Colegio, O.R., O'Connor, W. Jr., Sutterwale, F.S. and Flavell, R.A. (2008) Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453, 1122-1126.
4. Pasare, C. and Medzhitov, R. (2005) Control of Bcell responses by Toll-like receptors. Nature 438, 364-368.
5. Hardy, R.R. and Hayakawa, K. (2001) B cell developmental pathway. Annu. Rev. Immunol. 19, 595-621.
6. Berland, R. and Wortis, H.H. (2002) Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 20, 253-300.
7. Rastelli, J., Hömig-Hölzel, C., Seagal, J., Müller, W., Hermann, A.C., Rajewsky, K. and Zimber-Strobl, U. (2008) LMP1 signaling can replace CD40 signaling in B cells in vivo and has unique features of inducing class-switch recombination to IgG1. Blood 111, 1448-1455.
8. Honjo, T. and Kataoka, T. (1978) Organization of immunoglobulin heavy chain genes and allelic deletion model. Proc. Natl. Acad. Sci. U.S.A. 75, 2140-2144.
9. Stavnezer, J., Guikema, J.E. and Schrader, C.E. (2008) Mechanism and regulation of class switch recombination. Annu. Rev. Immunol. 26, 261-292.
10. Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y. and Honjo, T. (2000) Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102, 553-563.
11. Revy, P., Muto, T., Levy, Y., Geissman, F., Piebani, A., Sanal, O., Catalan, N., Forveille, M., Dufourcq-Labelouse, R., Gennery, A., Tezcan, I., Ersoy, F., Kayserill, H., Uqazio, A.G., Brousse, N., Muramatsu, M., Notaranqelo, L.D., Kinoshita, K., Honjo, T., Fisher, A. and Durandy, A. (2000) Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102, 565-575.
12. Shapiro-Shelef, M. and Calame, K. (2005) Regulation of plasma-cell development. Nat. Rev. Immunol. 5, 230-242.
13. Mittrucker, H.W., Matsuyama, T., Grossman, A., Kundig, T.M., Potter, J., Shahinian, A., Wakeham, A., Patterson, B., Ohashi, P.S. and Mak, T.W. (1997) Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 275, 540-543.
14. Kay, A.B. (2001) Allergy and allergic diseases. First of two parts. N. Engl. J. Med. 344, 30-37.
15. Galli, S.J., Tsai, M. and Piliponsky, A.M. (2008) The development of allergic inflammation. Nature 454, 445-454.
16. Nakajima, H. and Takatsu, K. (2007) Role of cytokines in allergic inflammation. Int. Arch. Allergy Immunol. 142, 265-273.
17. Dutton, R.W., Falkoff, R., Hirst, J.A., Hoffman, M., Kappler, J.W., Kettman, J.R., Lesley, J.F. and Van, D. (1971) Is there evidence for a nonantigen specific diffusable chemical mediator from the thymus-derived cell in the initiation of the immune response? Prog. Immunl. 1, 355-368.
18. Schimpl, A. and Wecker, E. (1972) Replacement of T-cell function by a T-cell product. Nature (New Biol.) 237, 15-17.
19. Kishimoto, T. and Hirano, T. (1988) Molecular regulation of B lymphocyte response. Annu. Rev. Immunol. 6, 485-512.
20. Paul, W.E. and Ohara, J. (1987) B-cell stimulatory factor-1/Interleukin 4. Annu. Rev. Immunol. 5, 429-459.
21. Takatsu, K., Haba, S., Aoki, T. and Kitagawa, M. (1974) Enhancing factor on anti-hapten antibody response released from PPDs-stimulated Tubercle bacilli-sensitized cells. Immunochemistry 11, 107-109.
22. Takatsu, K., Tominaga, A. and Hamaoka, T. (1980) Antigen-induced T cell-replacing factor (TRF). I. Functional characterization of a TRF-producing helper T cell subset and genetic studies on TRF production. J. Immunol. 124, 2414-2422.
23. Harada, N., Takahashi, T., Matsumoto, M., Kinashi, T., Kikuchi, Y., Koyama, N., Severinson, E., Yaoita, Y., Honjo, T., Yamaguchi, N., Tominaga, A. and Takatsu, K. (1987) Production of a monoclonal antibody useful in the molecular characterization of murine T-cell-replacing factor/B-cell growth factor II. Proc. Natl. Acad. Sci. U.S.A. 84, 4581-4585.
24. Kinashi, T., Harada, N., Severinson, E., Tanabe, T., Sideras, P., Konishi, M., Azuma, C., Tominaga, A., Bergstedt-Lindqvist, S., Takahashi, M., Matsuda, F., Yaoita, Y., Takatsu, K. and Honjo, T. (1986) Cloning of complementary DNA encoding T-cell replacing factor and identity with B-cell growth factor II. Nature 324, 70-73.
25. Takatsu, K., Tominaga, A., Harada, N., Mita, S., Matsumoto, M., Takahashi, T., Kikuchi, Y. and Yamaguchi, N. (1988) T cell-replacing factor (TRF)/interleukin 5 (IL-5): molecular and functional properties. Immunol. Rev. 102, 107-135.
26. Sanderson, C.J. (1992) Interleukin-5, eosinophils, and disease. Blood 79, 3101-3109.
27. Takatsu, K. and Nakajima, H. (2008) IL-5 and eosinophilia. Curr. Opin. Immunol. 20, 288-294.
28. Rothenberg, M.E. and Hogan, S.P. (2006) The eosinophil. Annu. Rev. Immunol. 24, 147-174.
29. Howard, M., Farrar, J., Hilfiker, M., Johnson, B., Takatsu, K., Hamaoka, T. and Paul, W.E. (1982) Identification of a T cell-derived B cell growth factor distinct from interleukin 2. J. Exp. Med. 155, 914-923.
30. Swain, S.L., Howard, M., Kappler, J., Marrack, P., Watson, J., Booth, R., Wetzel, G.D. and Dutton, R.W. (1983) Evidence for two distinct classes of murine B cell growth factors with activities in different functional assays. J. Exp. Med. 158, 822-835.
31. Sano, Y., Yamada, G., Dobashi, K., Mizuochi, T., Hamaoka, T. and Takatsu, K. (1984) Establishment of three PPD-reactive helper T cell clones with distinct functions in B cell activation. J. Immunol. 133, 629-635.
32. Tominaga, A., Takatsu, K. and Hamaoka, T. (1980) Antigen-induced T cell-replacing factor (TRF) II. X-linked gene control for the expression of TRFacceptor site(s) on B lymphocytes and preparation of specific antiserum to that acceptor. J. Immunol. 124, 2423-2429.
33. Takatsu, K., Sano, Y., Tomita, S., Hashimoto, N. and Hamaoka, T. (1981) Antibody against T cellreplacing factor acceptor site(s) augments in vivo primary IgM responses to suboptimal doses of heterologous erythrocytes. Nature 292, 360-362.
34. Takatsu, K. and Hamaoka, T. (1982) DBA/2Ha mice as a model of an X-linked immunodeficiency which is defective in the expression of TRFacceptor site(s) on B lymphocytes. Immunol. Rev. 64, 239-268.
35. Takatsu, K., Tanaka, K., Tominaga, A., Kumahara, Y. and Hamaoka, T. (1980) Antigen-induced T cell-replacing factor (TRF). III. Establishment of T cell hybridoma producing TRF and analysis of released TRF. J. Immunol. 125, 2646-2653.
36. Harada, N., Kikuchi, Y., Tominaga, A., Takaki, S. and Takatsu, K. (1985) BCGFII activity on activated B cells of a purified murine T cellreplacing factor (TRF) from a T cell hybridoma (B151K12). J. Immunol. 134, 3944-3951.
37. Takatsu, K., Harada, N., Hara, Y., Takahama, Y., Yamada, G., Dobashi, K. and Hamaoka, T. (1985) Purification and physicochemical characterization of murine T cell-replacing factor (TRF). J. Immunol. 134, 382-389.
38. Yamaguchi, Y., Hayashi, Y., Sugama, Y., Miura, Y., Kasahara, T., Torisu, T., Mita, S., Tominaga, A., Takatsu, K. and Suda, T. (1988) Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J. Exp. Med. 167, 1737-1742.
39. Yamaguchi, Y., Suda, T., Suda, J., Eguchi, M., Miura, Y., Harada, N., Tominaga, A. and Takatsu, K. (1988) Purified interleukin-5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J. Exp. Med. 167, 43-56.
40. Takatsu, K., Kikuchi, Y., Takahashi, T., Honjo, T., Matsumoto, M., Harada, N., Yamaguchi, N. and Tominaga, A. (1987) Interleukin 5, a T-cellderived B-cell differentiation factor also induces cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 84, 4234-4238.
41. Takatsu, K., Takaki, S. and Hitoshi, Y. (1994) Interleukin-5 and its receptor system in the immune system and inflammation. Adv. Immunol. 57, 145-190.
42. Honjo, T. and Takatsu, K. (1990) Interleukin-5. In Peptide Growth Factors and Their Receptor I (eds. Sporn, M.B. and Roberts, A.B.). Springer-Verlag, New York, pp. 609-632.
43. Azuma, C., Tanabe, T., Konishi, M., Kinashi, T., Noma, T., Matsuda, R., Yaoita, Y., Takatsu, K., Hammarstrom, L., Smith, L.I.E., Severinson, E. and Honjo, T. (1986) Cloning of cDNA encoding human T-cell replacing factor (Interleukin-5) and comparison with the murine homologue. Nucleic Acids Res. 14, 9149-9158.
44. Campbell, H.D., Tucker, W.Q.J., Hort, Y., Martinson, M.E., Mayo, G., Clutterbuck, E.J., Sanderson, C.J. and Young, I. (1987) Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor (interleukin-5). Proc. Natl. Acad. Sci. U.S.A. 84, 6629-6633.
45. Lee, H.J., Masuda, E.S., Arai, N., Arai, K. and Yokota, T. (1995) Definition of cis-regulatory elements of the interleukin-5 gene promoter. Involvement of nuclear factor of activated T cellrelated factors in interleukin-5 expression. J. Biol. Chem. 270, 17541-17550.
46. Le Beau, M.M., Lemons, E.R.S., Espinosa, R. III, Larson, R.A., Arai, N. and Rowley, J.D. (1988) IL-4 and IL-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemia with a del(5q). Blood 73, 647-650.
47. Zhang, D.-H., Yang, L. and Ray, A. (1998) Differential responsiveness of the IL-5 and IL-4 genes to transcription factor GATA-3. J. Immunol. 161, 3817-3821.
48. Yamashita, M., Ukai-Tadenuma, M., Miyamoto, T., Sugaya, K., Hosokawa, H., Hasegawa, A., Kimura, M., Taniguchi, M., DeGregali, J. and Nakayama, T. (2004) Essential role of GATA3 for the maintenance of type 2 helper T (Th2) cytokine production and chromatin remodeling at the Th2 cytokine gene loci. J. Biol. Chem. 279, 26983-26990.
49. Tominaga, A., Matsumoto, M., Harada, N., Takahashi, T., Kikuchi, Y. and Takatsu, K. (1988) Molecular properties and regulation of mRNA expression for murine T cell-replacing factor/IL-5. J. Immunol. 140, 1175-1181.
50. Tominaga, A., Takahashi, T., Kikuchi, Y., Mita, S., Naomi, S., Harada, N., Yamaguchi, N. and Takatsu, K. (1990) Role of carbohydrate moiety of IL-5. Effect of tunicamycin on the glycosylation of IL-5 and the biologic activity of deglycosylated IL-5. J. Immunol. 144, 1345-1352.
51. Milburn, M.V., Hassell, A.M., Lambert, M.H., Jordan, S.R., Proudfoot, A.E.I., Graber, P. and Wells, T.N.C. (1993) A novel dimer configuration revealed by the crystal structure at 2.4Å resolution of human interleukin-5. Nature 363, 172-176.
52. Dickason, R.R. and Huston, D.P. (1996) Creation of a biologically active interleukin-5 monomer. Nature 379, 652-655.
53. Mosmann, T.R. and Coffman, R.L. (1989) TH1 and TH2: different patterns of lympholine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145-173.
54. Moon, B.G., Takaki, S., Miyake, K. and Takatsu, K. (2004) The role of IL-5 for mature B-1 cells in homeostatic proliferation, cell survival, and Ig production. J. Immunol. 172, 6020-6029.
55. + Peyer's patch cells are a novel cell subset which secrete IL-5 in response to IL-2: implications for their role in IgA production. Eur. J. Immunol. 34, 1920-1929.
56. + lymphoid cells. Nature 463, 540-545.
57. Takatsu, K. (2011) Interleuikn 5 and the interleukin 5 receptor. In Eosinophils in Health and Diseases (eds. Lee, J.J. and Rosenberg, H.F.). Wiley, New York (in press).
58. Takeda, K., Haczku, A., Lee, J.J., Irvin, C.G. and Gelfand, E.W. (2001) Strain dependence of airway hyperresponsiveness reflects differences in eosinophil localization in the lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 281, L394-L402.
59. Tumes, D.J., Cormie, J., Calvert, M.G., Stewart, K., Nassenstein, C., Armin Braun, A., Foster, P.S. and Dent, L.A. (2007) Strain-dependent resistance to allergen-induced lung pathophysiology in mice correlates with rate of apoptosis of lungderived eosinophils. J. Leukoc. Biol. 81, 1362-1373.
60. Samoszuk, M. and Nansen, L. (1990) Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia. Blood 75, 13-16.
61. Takatsu, K., Dickason, R. and Huston, D. (1997) Interleukin-5. In Growth Factors and Cytokines in Health and Disease (eds. LeRoith, D. and Bondy, C.). JAI Press, London, pp. 143-200.
62. Mita, S., Harada, N., Naomi, N., Hitoshi, Y., Sakamoto, K., Akagi, M., Tominaga, A. and Takatsu, K. (1988) Receptors for T cell-replacing factor/interleukin 5. Specificity, quantitation, and its implication. J. Exp. Med. 168, 863-878.
63. Mita, S., Tominaga, A., Hitoshi, Y., Sakamoto, K., Honjo, T., Akagi, M., Kikuchi, Y., Yamaguchi, Y. and Takatsu, K. (1989) Characterization of highaffinity receptors for interleukin 5 on interleukin 5-dependent cell lines. Proc. Natl. Acad. Sci. U.S.A. 86, 2311-2315.
64. Yamaguchi, N., Hitoshi, Y., Mita, S., Hosoya, Y., Kikuchi, Y., Tominaga, A. and Takatsu, K. (1990) Characterization of the murine interleukin 5 receptor by using a monoclonal antibody. Int. Immunol. 2, 181-187.
65. + B cells. J. Immunol. 144, 4218-4225.
66. Rolink, A.G., Melchers, F. and Palacios, R. (1989) Monoclonal antibodies reactive with the mouse interleukin 5 receptor. J. Exp. Med. 169, 1693-1701.
67. Mita, S., Takaki, S., Hitoshi, Y., Rolink, A.G., Tominaga, A., Yamaguchi, N. and Takatsu, K. (1991) Molecular characterization of the β chain of the murine interleukin-5 receptor. Int. Immunol. 3, 665-672.
68. Takaki, S., Tominaga, A., Hitoshi, Y., Mita, S., Sonoda, E., Yamaguchi, N. and Takatsu, K. (1990) Molecular cloning and expression of the murine interleukin-5 receptor. EMBO J. 9, 4367-4374.
69. Kishimoto, T., Taga, T. and Akira, S. (1994) Cytokine signal transduction. Cell 76, 253-262.
70. Moon, B.G., Yoshida, T., Shiiba, M., Nakao, K., Katsuki, M., Takaki, S. and Takatsu, K. (2001) Functional dissection of the cytoplasmic subregions of the interleukin-5 receptor alpha chain in growth and immunoglobulin G1 switch recombination of B cells. Immunology 102, 289-300.
71. Murata, Y., Takaki, S., Migita, M., Kikuchi, Y., Tominaga, A. and Takatsu, K. (1992) Molecular cloning and expression of the human interleukin-5 receptor. J. Exp. Med. 175, 341-351.
72. Tavernier, J., Devos, R., Cornelis, S., Tuypens, T., Van der Heyden, J., Fiers, W. and Plaetinck, G. (1991) A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific α chain and a β chain shared with the receptor for GM-CSF. Cell 66, 1175-1184.
73. Tavernier, J., Tuypens, T., Verhee, A., Plaetinck, G., Devos, R., Van der Heyden, J., Guisez, Y. and Oefner, C. (1995) Identication of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist. Proc. Natl. Acad. Sci. U.S.A. 92, 5194-5198.
74. Miyajima, A., Kitamura, T., Harada, N., Yokota, T. and Arai, K. (1992) Cytokine receptors and signal transduction. Annu. Rev. Immunol. 10, 295-331.
75. Takaki, S., Mita, S., Kitamura, T., Yonehara, S., Yamaguchi, N., Tominaga, A., Miyajima, A. and Takatsu, K. (1991) Identification of the second subunit of the murine interleukin-5 receptor: interleukin-3 receptor-like protein, AIC2B is a component of the high affinity interleukin-5 receptor. EMBO J. 10, 2833-2838.
76. Ogata, N., Kouro, T., Yamada, A., Koike, M., Hanai, N., Ishikawa, T. and Takatsu, K. (1998) JAK2 and JAK1 constitutively associate with an interleukin 5 (IL-5) receptor and βc subunit, respectively and are activated upon IL-5 stimulation. Blood 91, 2264-2271.
77. Takaki, S., Kanazawa, H., Shiiba, M. and Takatsu, K. (1994) A critical cytoplasmic domain of the interleukin-5 (IL-5) receptor α chain and its function in IL-5-mediated growth signal transduction. Mol. Cell. Biol. 14, 7404-7413.
78. Kouro, T., Kikuchi, Y., Kanazawa, H., Hirokawa, K., Harada, N., Shiiba, M., Wakao, H., Takaki, S. and Takatsu, K. (1996) Critical proline residues of the cytoplasmic domain of the IL-5 receptor alpha chain and its function in IL-5-mediated activation of JAK kinase and STAT5. Int. Immunol. 8, 237-245.
79. Takaki, S., Murata, Y., Kitamura, T., Miyajima, A., Tominaga, A. and Takatsu, K. (1993) Reconstitution of the functional receptors for murine and human interleukin 5. J. Exp. Med. 177, 1523-1529.
80. Mirza, S., Chen, J., Wen, B., Ewens, C.L., Dai, J., Murphy, J.M. and Young, I.G. (2010) Two modes of beta-receptor recognition are mediated by distinct epitopes on mouse and human interleukin-3. J. Biol. Chem. 285, 22370-22381.
81. Zaks-Zilberman, M., Hamington, A.E., Ishino, T. and Chaikaen, I.M. (2008) Interleukin-5 receptor subunit oligomerization and rearrangement revealed by fluorescence resonance energy transfer imaging. J. Biol. Chem. 283, 13398-13406.
82. Martinez-Moczygemba, M. and Huston, D.P. (2001) Proteasome regulation of βc signaling reveals a novel mechanism for heterotypic desensitization. J. Clin. Invest. 108, 1797-1806.
83. Hitoshi, Y., Sonoda, E., Kikuchi, Y., Yonehara, S., Nakauchi, H., Tominaga, A. and Takatsu, K. (1993) Interleukin-5 receptor positive B cells, but not eosinophils are functionally and numerically influenced in the mice carried with X-linked immunodeficiency. Int. Immunol. 5, 1183-1190.
84. Tominaga, A., Takaki, S., Koyama, N., Katoh, S., Matsumoto, R., Migita, M., Hitoshi, Y., Hosoya, Y., Yamauchi, S., Kanai, Y., Miyazaki, J.-I., Usuku, G., Yamamura, K.-I. and Takatsu, K. (1991) Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production. J. Exp. Med. 173, 429-437.
85. Yoshida, T., Ikuta, K., Sugaya, H., Maki, K., Takagi, M., Kanazawa, H., Sunaga, S., Kinashi, T., Yoshimura, K., Miyazaki, J., Takaki, S. and Takatsu, K. (1996) Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5R,-deficient mice. Immunity 4, 483-494.
86. Hiroi, T., Yanagita, M., Iijima, H., Iwatani, K., Yoshida, T., Takatsu, K. and Kiyono, H. (1999) Deficiency of IL-5 receptor,-chain selectively influences the development of the common mucosal immune system independent IgA-producing B-1 cell in mucosa-associated tissues. J. Immunol. 162, 821-828.
87. Kouro, T., Ikutani, M., Kariyone, A. and Takatsu, K. (2009) Expression of IL-5R, on B-1 cell progenitors in mouse fetal liver and involvement of Bruton's tyrosine kinase in their development. Immunol. Lett. 123, 169-178.
88. Emslie, D., D'Costa, K., Hasbold, J., Metcalf, D., Takatsu, K., Hodgkin, P.O. and Corcoran, L.M. (2008) Oct2 enhances antibody-secreting cell differentiation through regulation of IL-5 receptor alpha chain expression on activated B cells. J. Exp. Med. 205, 409-421.
89. Takatsu, K., Kouro, T. and Nagai, Y. (2009) Interleukin-5 and its receptor system in the immune system and inflammation. Adv. Immunol. 57, 145-190.
90. Ashizawa, Y. (2002). Transcriptional regulation of the IL-5R α chain expression of mouse B cells. Thesis, the University of Tokyo.
91. Iwasaki, H., Mizuno, S., Mayfield, R., Shigematsu, H., Arinobu, Y., Seed, B., Gurish, M.F., Takatsu, K. and Akashi, K. (2005) Identification of eosinophil lineage-committed progenitors in the murine bone marrow. J. Exp. Med. 201, 1891-1897.
92. Sun, Z., Yergeau, D.A., Tuypens, T., Tavernier, J., Paul, C.C., Baumann, M.A., Tenen, D.G. and Ackerman, S.J. (1995) Identification and characterization of a functional promoter region in the human eosinophil IL-5 receptor alpha subunit gene. J. Biol. Chem. 270, 1462-1471.
93. Iwama, A., Pan, J., Zhang, P., Reith, W., Mach, B., Tenen, D.G. and Sun, Z. (1999) Dimeric RFX proteins contribute to the activity and lineage specificity of the interleukin-5 receptor alpha promoter through activation and repression domains. Mol. Cell. Biol. 19, 3940-3950.
94. Satoh, S., Katagiri, T., Takaki, S., Kikuchi, Y., Hitoshi, Y., Yonehara, S., Tsukada, S., Kitamura, D., Watanabe, T., Witte, O.N. and Takatsu, K. (1995) IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus-2 kinases. J. Exp. Med. 180, 2101-2111.
95. Takatsu, K. (1998) Interleukin 5 and B cell differentiation. Cytokine Growth Factor Rev. 9, 25-35.
96. Zahn, S., Godillot, P., Yoshimura, A. and Chaiken, I. (2000) IL-5-Induced JAB-JAK2 interaction. Cytokine 12, 299-306.
97. Horikawa, K., Kaku, H., Nakajima, H., Davey, H.W., Hennighausen, L., Iwamoto, I., Yasue, T., Kariyone, A. and Takatsu, K. (2001) Essential role of Stat5 for IL-5-dependent IgH switch recombination in mouse B cells. J. Immunol. 167, 5018-5026.
98. Huang, H.M., Lee, Y.L. and Chang, T.W. (2006) JAK1 N-terminus binds to conserved Box 1 and Box 2 motifs of cytokine receptor common beta subunit but signal activation requires JAK1 Cterminus. J. Cell. Biochem. 99, 1078-1084.
99. Kagami, S., Nakajima, H., Kumano, K., Suzuki, K., Suto, A., Imada, K., Davey, H.W., Saito, Y., Takatsu, K., Leonard, W.J. and Iwamoto, I. (2000) Both Stat5a and Stat5b are required for antigen-induced eosinophil and T-cell recruitment into the tissue. Blood 95, 1370-1377.
100. Meads, M.B., Li, Z.W. and Dalton, W.S. (2010) A novel TNF receptor-associated factor 6 binding domain mediates NF-5B signaling by the common cytokine receptor beta subunit. J. Immunol. 185, 1606-1615.
101. Martinez-Moczygemba, M., Huston, D.P. and Lei, J.T. (2007) JAK kinases control IL-5 receptor ubiquitination, degradation and internalization. J. Leukoc. Biol. 81, 1137-1148.
102. Tsukada, S., Saffran, D.C., Rawling, D.J., Parolini, O., Allen, R.C., Klisak, I., Sparkes, R.S., Kubagawa, H., Mohandas, T., Quan, S., Belmont, J.W., Cooper, M.D., Conley, M.E. and Witte, N. (1993) Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72, 279-290.
103. Yasue, T., Nishizumi, H., Aizawa, S., Yamamoto, T., Miyake, K., Mizoguchi, C., Uehara, S., Kikuchi, Y. and Takatsu, K. (1997) A critical role of Lyn and Fyn for B cell responses to CD38 ligation and interleukin 5. Proc. Natl. Acad. Sci. U.S.A. 94, 10307-10312.
104. Kikuchi, Y., Hirano, M., Seto, M. and Takatsu, K. (2000) Identification and characterization of a molecule, BAM11, that associates with the pleckstrin homology domain of mouse Btk. Int. Immunol. 12, 1397-1408.
105. Hirano, M., Kikuchi, Y., Nisitani, S., Yamaguchi, A., Sato, A., Ito, T., Iba, H. and Takatsu, K. (2004) Bruton's tyrosine kinase (Btk) enhances transcriptional co-activation activity of BAM11, a Btk-associated molecule of a subunit of SWI/SNF complexes. Int. Immunol. 16, 747-757.
106. Pazdrak, K., Schreiber, D., Forsythe, P., Justement, L. and Alam, R. (1995) The intracellular signal transduction mechanism of interleukin 5 in eosinophils: the involvement of lyn tyrosine kinase and the Ras-Raf-1-MEK-microtubule-associated protein kinase pathway. J. Exp. Med. 181, 1827-1834.
107. Inoue, H., Kato, R., Fukuyama, S., Nonami, A., Taniguchi, K., Matsumoto, K., Nakano, T., Tsuda, M., Matsumura, M., Kubo, M., Ishikawa, F., Moon, B.-G., Takatsu, K., Nakanishi, Y. and Yoshimura, A. (2005) Spred-1 negatively regulates allergen-induced airway eosinophilia and hyperresponsiveness. J. Exp. Med. 201, 73-82.
108. Busslinger, M. (2004) Transcriptional control of early B cell development. Annu. Rev. Immunol. 22, 55-79.
109. Sonoda, E., Matsumoto, R., Hitoshi, Y., Mita, S., Ishii, N., Sugimoto, M., Araki, S., Tominaga, A., Yamaguchi, N. and Takatsu, K. (1989) Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production. J. Exp. Med. 170, 1415-1420.
110. Honjo, T. (2008) A memoir of AID, which engraves antibody memory on DNA. Nat. Immunol. 9, 335-337.
111. Rada, C., Williams, G.T., Nilsen, H., Barnes, D.E., Lindahl, T. and Neuberger, M.S. (2002) Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr. Biol. 12, 1748-1755.
112. Mizoguchi, C., Uehara, S., Akira, S. and Takatsu, K. (1999) IL-5 induces IgG1 isotype switch recombination in mouse CD38-activated sIgDpositive B lymphocytes. J. Immunol. 162, 2812-2819.
113. Kaku, H., Horikawa, K., Obata, Y., Kato, I., Okamoto, H., Sakaguchi, N., Gerondakis, S. and Takatsu, K. (2002) NF-5B is required for CD38-mediated induction of C.1 germline transcripts in murine B lymphocytes. Int. Immunol. 14, 1055-1064.
114. Horikawa, K. and Takatsu, K. (2006) Interleukin-5 regulates genes involved in B cell terminal maturation. Immunology 118, 497-508.
115. Tsukamoto, Y., Uehara, S., Mizoguchi, C., Sato, A., Horikawa, K. and Takatsu, K. (2005) Requirement of 8-mercaptoguanosine as a costimulus for IL-4-dependent 7 to .1 class switch recombination in CD38-activated B cells. Biochem. Biophys. Res. Commun. 336, 625-633.
116. Tsukamoto, Y., Nagai, Y., Kaisho, T., Akira, S., Miyake, K. and Takatsu, K. (2009) Toll-like receptor 7 cooperates with antigen receptors and CD38 for induction of class switch recombination and terminal B cell maturation. Mol. Immunol. 46, 1276-1288.
117. Takatsu, K. and Nakajima, H. (2008) IL-5 and eosinophilia. Curr. Opin. Immunol. 20, 288-295.
118. Tanaka, H., Kawada, N., Yamada, T., Kawada, K., Takatsu, K. and Nagai, H. (2000) Allergeninduced airway inflammation and bronchial responsiveness in interleukin-5 receptor α chaindeficient mice. Clin. Exp. Allergy 30, 874-881.
119. + B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 4, 15-24.
120. + T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am. Rev. Respir. Dis. 146, 374-377.
121. Akutsu, I., Kojima, T., Kariyone, A., Fukuda, T., Makino, S. and Takatsu, K. (1995) Antibody against interleukin-5 prevents antigen-induced eosinophil infiltration and bronchial hyper- reactivity in the guinea pig airways. Immunol. Lett. 45, 109-116.
122. Mauser, P.J., Pitman, A.M., Fernandez, X., Foran, S.K., Adams, G.K. III, Kreutner, W. and Chapman, R.W. (1995) Effects of an antibody to IL-5 in a monkey model of asthma. Am. J. Respir. Crit. Care Med. 152, 467-472.
123. Leckie, M.J., ten Brinke, A., Khan, J., Diamant, Z., O'Connor, B.J., Walls, C.M., Mathur, A.K., Cowley, H.C., Chung, K.F., Djukanovic, R., Hansel, T.T., Holgate, S.T., Sterk, P.J. and Barnes, P.J. (2000) Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356, 2144-2148.
124. Flood-Page, P., Swenson, C., Faiferman, I., Matthews, J., Williams, M., Brannick, L., Robinson, D., Wenzel, S., Busse, W., Hansel, T.T. and Barnes, N.C. (2007) International Mepolizumab Study Group: A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. Am. J. Respir. Crit. Care Med. 176, 1062-1071.
125. Rothenberg, M.E. and Hogan, S.P. (2006) The eosinophil. Annu. Rev. Immunol. 24, 147-174.
126. Rothenberg, M.E., Klion, A.D., Roufosse, F.E., Kahn, E.J., Weller, P.F., Simon, H-U., Schwartz, L.B., Rosenwasser, L.J., Ring, J., Griffin, E.F., Haig, A.E., Frewer, P.I.H., Parkin, J.M., Gleich, G.J. and Mepolizumab HES Study Group (2008) Treatment of patients with the hypereosinophilic syndrome with mepolizumab. N. Engl. J. Med. 358, 1215-1228.
127. Koike, M., Nakamura, K., Furuya, A., Iida, A., Anazawa, H., Takatsu, K. and Hanai, N. (2009) Establishment of humanized anti-interleukin-5 receptor alpha chain monoclonal antibodies having a potent neutralizing activity. Hum. Antibodies 18, 17-27.
128. Shinkawa, T., Nakamura, K., Yamane, N., Shoji-Hosaka, E., Kanda, Y., Sakurada, M., Uchida, K., Anazawa, H., Satoh, M., Yamasaki, M., Hanai, N. and Shitara, K. (2003) The absence of fucose but not the presence of galactose or bisecting Nacetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J. Biol. Chem. 278, 3466-3473.
129. Kolbeck, R., Alexander Kozhich, A., Koike, M., Peng, L., Andersson, C.K., Damschroder, M.M., Reed, J.L., Woods, R., Dall'Acqua, W.W., Stephens, G.L., Erjefalt, J.S., Bjermer, L., Humbles, A.A., Gossage, D., Wu, H., Kiener, P.A., Spitalny, G.L., Mackay, C.R., Molfino, N.A. and Coyle, A.J. (2010) MEDI-563, a humanized anti-IL-5 receptor α mAb with enhanced antibody-dependent cell-mediated cytotoxicity function. J. Allergy Clin. Immunol. 125, 1344-1353.
130. Busse, W.W., Katial, R., Gossage, D., Sari, S., Wang, B., Kolbeck, R., Coyle, A.J., Koike, M., Spitalny, G.L., Kiener, P.A., Geba, G.P. and Molfino, N.A. (2010) Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor α antibody, in a phase I study of subjects with mild asthma. J. Allergy Clin. Immunol. 125, 1237-1244.